Precision Medicine
Medical AI
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Jul 2025 · 15 mo ago
Grants
$2.5M
4 grants · CORDIS
Backers
3
Entrepreneur First, Hoxton Ventures
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1
Won a grant $889k · CORDIS
Apr 21
Launched Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 · marketwatch.com
Sep 1, 2025
Won a grant $444k · CORDIS
Jul 22, 2025
Raised a round Venture round
Jan 14, 2025
Launched Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer · panakeia.ai
Aug 14, 2024
Raised a round Venture round
Aug 1, 2024
Won a grant $727k · CORDIS
Jan 24, 2024
Raised a round Venture round
May 1, 2023
Won a grant $442k · CORDIS
Mar 29, 2023
Raised a round Venture round
Mar 5, 2020
Raised a round Venture round
Sep 26, 2019
Raised a round Venture round
Nov 26, 2018
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jul 2026 | $889k | — | CORDIS |
| Grant | Sep 2025 | $444k | — | CORDIS |
| Venture round | Jul 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Aug 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Aug 2024 | $727k | — | CORDIS |
| Venture round | Jan 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | May 2023 | $442k | — | CORDIS |
| Venture round | Mar 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Mar 2020 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Sep 2019 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | PANAKEIA TECHNOLOGIES LIMITED | Companies House |
| Registered | 26 Nov 2018 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Ataraxis AI is a medical artificial intelligence company that builds foundation models for cancer care. Its first product, Ataraxis Breast…

StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics.

Medicus (MedicusAI) develops AI-powered digital pathology and precision oncology solutions for hospitals, labs, and pharma partners.

Concr is a London biotechnology company founded in 2020 that models tumour biology to predict how patients will respond to cancer drugs…

Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…

Aignostics is a Berlin company founded in 2018 as a spin-out from the Charité hospital and its artificial intelligence institute. Its…
Overview
Panakeia is a London medical technology company founded in 2018 that predicts molecular tumour profiles from routine pathology slides. Its models aim to give oncologists genomic-level insight without waiting weeks for sequencing. The company works with hospitals and pharmaceutical partners on cancer diagnostics.
News
Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026
CAMBRIDGE, UK - April 21, 2026 - Panakeia (
Read more
Report
Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026
CAMBRIDGE, UK - April 21, 2026 - Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual Meeting 2026, further prov
Read more
Report
Report
Panakeia to attend and present at upcoming scientific and business conferences
Cambridge, UK, 16 April 2026 - Panakeia ("the Company"), the world's first in silico multi-omics company, is pleased to confirm that it will be attending and presenting at a number of conferences in April and May 2026. AACR Annual Meeting - April 17 - 22,
Read more
Report
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer
Largest real-world, blinded, multi-site validation of AI molecular profiling from routine diagnostic images Software identifies clinically actionable cancer biomarkers in minutes rather than weeks Study led by University of Leeds and Leeds Teaching Hospit
Read more
Report
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer
Read more
Report
Panakeia to attend upcoming scientific and business conferences
Cambridge, UK, 3 November 2025 - Panakeia ("the Company"), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm that various team members will be attending and presenting at a number of conferences as detailed below. Panakeia's AI
Read more
Report
Panakeia to attend and present at upcoming scientific and business conferences
Cambridge, UK, 5 September 2025 - Panakeia ("the Company"), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to...
Read more
Report
Financial Services Commission fines Panakeia 1.05 billion won for accounting violations
Financial Services Commission fines Panakeia 1.05 billion won for accounting violations Penalties issued for accounting discrepancies highlight signif
Read more
Report
Panakeia to attend and present at upcoming scientific and business conferences
Cambridge, UK, 9 April 2025 - Panakeia ("the Company"), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ
Financials
Total raised
$2.5M
Latest round
Grant
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2026 | $889k | Details |
| Grant | 2025 | $444k | Details |
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Grant | 2024 | $727k | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Grant | 2023 | $442k | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2020 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |

Entrepreneur First
Hoxton Ventures 



